ORTEGA MUNOZ; Alberto

Patent Applications and Registrations

Patent applications and USPTO patent grants for ORTEGA MUNOZ; Alberto.The latest application filed is for "3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibitors".

Company Profile

0.22.21

ORTEGA MUNOZ; Alberto - Vilassar de Dalt ES
Ortega Munoz; Alberto - Barcelona ES
Ortega Munoz; Alberto - Santa Coloma de Gramenet ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole Derivatives As Hdac6 Inhibitors App 20220298156 - CARCELLER GONZ LEZ; Elena ; et al.	2022-09-22
Methods to determine KDM1A target engagement and chemoprobes useful therefor Grant 11,034,991 - Carceller Gonzalez , et al. June 15, 2	2021-06-15
1,2,4-oxadiazole Derivatives As Histone Deacetylase 6 Inhibitors App 20200339569 - CARCELLER GONZ LEZ; Elena ; et al.	2020-10-29
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,329,256 - Ortega Munoz , et al.	2019-06-25
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 10,233,178 - Ortega Munoz , et al.	2019-03-19
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,214,477 - Ortega Munoz , et al. Feb	2019-02-26
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180354902 - Ortega Munoz; Alberto ; et al.	2018-12-13
Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use App 20180127406 - ORTEGA MUNOZ; Alberto ; et al.	2018-05-10
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,944,601 - Ortega Munoz , et al. April 17, 2	2018-04-17
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180079709 - ORTEGA MUNOZ; Alberto ; et al.	2018-03-22
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 9,708,309 - Ortega Munoz , et al. July 18, 2	2017-07-18
Cyclopropylamine derivatives useful as LSD1 inhibitors Grant 9,676,701 - Fyfe , et al. June 13, 2	2017-06-13
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,670,136 - Ortega Munoz , et al. June 6, 2	2017-06-06
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20170008844 - ORTEGA MUNOZ; Alberto ; et al.	2017-01-12
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20160368857 - ORTEGA MUNOZ; Alberto ; et al.	2016-12-22
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,487,512 - Ortega Munoz , et al. November 8, 2	2016-11-08
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,469,597 - Ortega Munoz , et al. October 18, 2	2016-10-18
Cyclopropylamine Derivatives Useful As Lsd1 Inhibitors App 20160052865 - FYFE; Matthew Colin Thor ; et al.	2016-02-25
Phenylcyclopropylamine Derivatives And Their Medical Use App 20160045456 - GUIBOURT; Nathalie ; et al.	2016-02-18
Cyclopropylamine Inhibitors Of Oxidases App 20160000768 - Castro-Palomino Laria; Julio ; et al.	2016-01-07
Arylcyclopropylamine Based Demethylase Inhibitors Of Lsd1 And Their Medical Use App 20150376177 - ORTEGA MUNOZ; Alberto ; et al.	2015-12-31
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use Grant 9,181,198 - Ortega Munoz , et al. November 10, 2	2015-11-10
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20150119396 - Ortega Munoz; Alberto ; et al.	2015-04-30
Cyclopropylamine derivatives useful as LSD1 inhibitors Grant 9,006,449 - Fyfe , et al. April 14, 2	2015-04-14
Phenylcyclopropylamine derivatives and their medical use Grant 8,993,808 - Guibourt , et al. March 31, 2	2015-03-31
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use Grant 8,946,296 - Ortega Munoz , et al. February 3, 2	2015-02-03
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20150025054 - Ortega Munoz; Alberto ; et al.	2015-01-22
Lysine Specific Demethylase-1 inhibitors and their use Grant 8,859,555 - Ortega Munoz , et al. October 14, 2	2014-10-14
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20140256729 - Ortega Munoz; Alberto ; et al.	2014-09-11
Lysine specific demethylase-1 inhibitors and their use Grant 8,722,743 - Ortega Munoz , et al. May 13, 2	2014-05-13
Lysine Specific Demethylase-1 Inhibitors And Their Use App 20130090386 - Ortega Munoz; Alberto ; et al.	2013-04-11
Lysine Specific Demethylase-1 Inhibitors And Their Use App 20120283266 - Ortega Munoz; Alberto ; et al.	2012-11-08
Substituted Heteroaryl- And Aryl-cyclopropylamine Acetamides And Their Use App 20120264823 - Ortega Munoz; Alberto ; et al.	2012-10-18
Phenylcyclopropylamine Derivatives And Their Medical Use App 20120004262 - Guibourt; Nathalie ; et al.	2012-01-05
Oxidase inhibitors and their use App 20110263604 - Guibourt; Nathalie ; et al.	2011-10-27
Derivatives Of 4-(2-amino-1-hydroxyethyl)phenol As Agonists Of The Beta2 Adrenergic Receptor App 20100168161 - Tana; Jordi Bach ; et al.	2010-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.